Farther Finance Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Sell
36,313
-20,587
-36% -$920K 0.01% 860
2026
Q1
$2.72M Buy
56,900
+14,605
+35% +$681K 0.03% 526
2025
Q4
$2.05M Buy
42,295
+25,098
+146% +$1.24M 0.02% 570
2025
Q3
$812K Buy
17,197
+11,486
+201% +$554K 0.01% 835
2025
Q2
$276K Sell
5,711
-504
-8% -$25.8K 0.01% 1232
2025
Q1
$338K Buy
6,215
+2,476
+66% +$134K 0.01% 989
2024
Q4
$180K Buy
3,739
+878
+31% +$44.6K 0.01% 1036
2024
Q3
$165K Buy
2,861
+309
+12% +$16.7K 0.01% 1077
2024
Q2
$127K Buy
2,552
+462
+22% +$22.3K 0.01% 1030
2024
Q1
$101K Buy
2,090
+366
+21% +$17.9K 0.01% 941
2023
Q4
$85.8K Buy
1,724
+691
+67% +$33.8K 0.01% 844
2023
Q3
$55.4K Buy
1,033
+417
+68% +$22.2K 0.01% 740
2023
Q2
$33.2K Buy
616
+127
+26% +$6.83K 0.01% 814
2023
Q1
$26.6K Buy
489
+54
+12% +$2.63K 0.01% 815
2022
Q4
$21.1K Buy
+435
New +$19.1K 0.01% 718

Other funds holding SNY

Farther Finance Advisors's SNY Position: Q2 2026 in Review

Farther Finance Advisors reduced its Sanofi (SNY) stake by 36% in Q2 2026, selling an estimated $920K and leaving 36,313 shares worth $1.55M. The position accounts for 0.01% of the portfolio, ranked #860.

Farther Finance Advisors first reported a position in SNY in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.72M in Q1 2026. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Farther Finance Advisors held 36,313 shares of Sanofi worth $1.55M as of Q2 2026.
  • Farther Finance Advisors sold 20,587 Sanofi shares in Q2 2026, an estimated $920K.
  • Sanofi made up 0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #860 holding.
  • Farther Finance Advisors first reported a position in Sanofi in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's Sanofi position peaked at $2.72M in Q1 2026.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.